Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal Cancer

The addition of trastuzumab to chemotherapy was demonstrated to be beneficial for advanced human epidermal growth factor receptor-2 (HER-2) positive gastric cancer. However, the HER-2 status of rectal cancer remains uncertain. This study aimed to determine the HER-2 expression in a large multicenter...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Xiangjiao, Huang, Zhaoqin, Di, Jian, Mu, Dianbin, Wang, Yawei, Zhao, Xianguang, Zhao, Hanxi, Zhu, Wanqi, Li, Xiaolin, Kong, Lingling, Xing, Ligang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058996/
https://www.ncbi.nlm.nih.gov/pubmed/26632727
http://dx.doi.org/10.1097/MD.0000000000002106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058996/
https://www.ncbi.nlm.nih.gov/pubmed/26632727
http://dx.doi.org/10.1097/MD.0000000000002106

Ejemplares similares